Pinnacle Clinical Research Adds Five Sites to Network (KMC, CRCNJ, Bellaire, Palmetto, DRI)

Summit Clinical Research (with Pinnacle) Acquires Houston Research Institute

February 28, 2025

Healthcare Services

LongueVue Capital portfolio company Summit Clinical Research, in partnership with Pinnacle Clinical Research, completed a strategic investment in Houston Research Institute (HRI) to expand Summit's metabolic/hepatology clinical research capabilities. The transaction brings HRI's scientific expertise into Summit/Pinnacle's site network and is accompanied by leadership additions — Dr. Mazen Noureddin named Co-Chairman (and Chief Scientific Officer), Dr. Naim Alkhouri as Chief Academic Officer, and Brandon Early as President.

Pinnacle Clinical Research (LongueVue Capital) Combines with South Texas Research Institute

January 10, 2023

Healthcare Services

Pinnacle Clinical Research, a LongueVue Capital portfolio company, has completed a combination with South Texas Research Institute (STRI). The deal expands Pinnacle's clinical site network to six dedicated locations, strengthens recruitment capabilities (notably for NASH/NAFLD trials) and increases geographic reach into the Rio Grande Valley.

Pinnacle Clinical Research Acquires Jubilee Clinical Research

September 27, 2024

Healthcare Services

LongueVue Capital-backed Pinnacle Clinical Research has acquired Jubilee Clinical Research, a Las Vegas-based multi-therapeutic clinical trial site focused on metabolic and cardiovascular indications. The add-on expands Pinnacle's West Coast footprint and therapeutic expertise; Jubilee's founder Dr. Elliot Shin will continue to lead the site within the Pinnacle network.

LongueVue Capital Invests in Pinnacle Clinical Research

November 16, 2022

Healthcare Services

LongueVue Capital, a New Orleans-based private equity firm, completed a growth investment in Pinnacle Clinical Research, a San Antonio-based multi-location clinical trial site network specializing in complex therapeutic areas including hepatology (NAFLD/NASH). The capital from LVC is intended to support Pinnacle’s organic and inorganic growth, expand clinical trial capacity, and enhance operational capabilities across its Texas sites.

Pinnacle Treatment Centers Acquires Four Outpatient Opioid Treatment Programs from Recovery Centers of America

April 5, 2023

Healthcare Services

Pinnacle Treatment Centers, a Mt. Laurel, New Jersey-based addiction treatment provider, has acquired four outpatient opioid addiction treatment programs (one in Pennsylvania and three in New Jersey) that were previously operated by Recovery Centers of America. The facilities—now renamed Lansdowne Treatment Services, Trenton Treatment Services, Somerdale Treatment Services, and Woodbridge Treatment Services—will provide medication-assisted treatment (MAT) and expand Pinnacle's community-based network in the Eastern U.S.

Alcanza Clinical Research Acquires Innovation Medical Research Center

April 9, 2024

Healthcare Services

Alcanza Clinical Research, a portfolio company of Martis Capital, has acquired Innovation Medical Research Center, a multi-specialty clinical research site located in Palmetto Bay, Florida. The add-on expands Alcanza’s therapeutic-area capabilities and patient diversity across its investigator site network as part of an ongoing roll-up strategy.